AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Amerant Bancorp
AMTB
$1.16B
| $671K | ﹤0.01% |
27,000
+1,000
| +4% | +$27.2K |
|
2502
Conduent
CNDT
$244M
| $671K | ﹤0.01% |
200,882
+240
| +0.1% | +$1K |
|
2503
Seres Therapeutics
MCRB
$46.8M
| $668K | ﹤0.01% |
5,205
+560
| +12% | +$57.4K |
|
|
AUS
2504
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $667K | ﹤0.01% |
67,999
| – | – |
|
2505
SandRidge Energy
SD
$514M
| $665K | ﹤0.01% |
40,803
| – | – |
|
2506
Relmada Therapeutics
RLMD
$557M
| $663K | ﹤0.01% |
17,900
-59,132
| -77% | -$1.64M |
|
2507
Hims & Hers Health
HIMS
$6.43B
| $660K | ﹤0.01% |
118,200
+58,100
| +97% | +$350K |
|
2508
Horizon Bancorp
HBNC
$1.04B
| $659K | ﹤0.01% |
36,678
-2,255
| -6% | -$42.4K |
|
2509
Columbus McKinnon
CMCO
$553M
| $657K | ﹤0.01% |
25,100
+800
| +3% | +$24.4K |
|
2510
RPC Inc
RES
$1.24B
| $655K | ﹤0.01% |
94,561
-24,280
| -20% | -$176K |
|
|
GDEN
2511
DELISTED
Golden Entertainment
GDEN
| $650K | ﹤0.01% |
18,620
+270
| +1% | +$10.8K |
|
|
AY
2512
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $650K | ﹤0.01% |
24,722
-15,088
| -38% | -$499K |
|
|
SQSP
2513
DELISTED
Squarespace, Inc.
SQSP
| $650K | ﹤0.01% |
30,409
+9,949
| +49% | +$217K |
|
2514
Peoples Bancorp
PEBO
$1.5B
| $647K | ﹤0.01% |
22,349
| – | – |
|
2515
Sana Biotechnology
SANA
$871M
| $646K | ﹤0.01% |
107,595
| – | – |
|
|
TGI
2516
DELISTED
Triumph Group
TGI
| $645K | ﹤0.01% |
75,095
+1,834
| +3% | +$24K |
|
|
PYCR
2517
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $642K | ﹤0.01% |
21,718
-59
| -0.3% | -$1.71K |
|
|
TPIC
2518
DELISTED
TPI Composites
TPIC
| $641K | ﹤0.01% |
56,829
-38,178
| -40% | -$604K |
|
2519
Petco
WOOF
$797M
| $641K | ﹤0.01% |
57,420
-168
| -0.3% | -$2.45K |
|
|
CTIC
2520
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $641K | ﹤0.01% |
110,200
+14,100
| +15% | +$87.9K |
|
2521
International Money Express
IMXI
$357M
| $640K | ﹤0.01% |
28,100
+8,900
| +46% | +$209K |
|
2522
iShares US Real Estate ETF
IYR
$4.66B
| $640K | ﹤0.01% |
7,865
+127
| +2% | +$12K |
|
2523
Clover Health Investments
CLOV
$2.2B
| $639K | ﹤0.01% |
375,800
| – | – |
|
2524
Artivion
AORT
$1.3B
| $638K | ﹤0.01% |
46,082
+68
| +0.1% | +$1.37K |
|
2525
Reynolds Consumer Products
REYN
$5.26B
| $637K | ﹤0.01% |
24,477
-81
| -0.3% | -$2.29K |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.